|
|
-
143 (45%) experienced major efficacy
-
93 (29%) experienced moderate efficacy
-
32 (10%) experienced slight efficacy
-
16 (5%) experienced no efficacy
-
|
-
60 (19%) experienced severe side effects
-
102 (32%) experienced moderate side effects
-
101 (31%) experienced mild side effects
-
58 (18%) experienced no side effects
|
321 |
Lamotrigine
(Lamictal, Apo-Lamotrigine, Lamictal ODT Green Titration Kit, Lamictal XR)
|
-
90 (41%) experienced major efficacy
-
61 (28%) experienced moderate efficacy
-
31 (14%) experienced slight efficacy
-
13 (6%) experienced no efficacy
-
|
-
24 (11%) experienced severe side effects
-
71 (32%) experienced moderate side effects
-
72 (33%) experienced mild side effects
-
54 (24%) experienced no side effects
|
221 |
Carbamazepine
(Novo-Carbamazepine, Hermolepsin retard, Teril, Carbatrol ER)
|
-
65 (40%) experienced major efficacy
-
44 (27%) experienced moderate efficacy
-
24 (15%) experienced slight efficacy
-
11 (7%) experienced no efficacy
-
|
-
34 (21%) experienced severe side effects
-
58 (36%) experienced moderate side effects
-
43 (27%) experienced mild side effects
-
27 (17%) experienced no side effects
|
162 |
Topiramate
(Topamax Sprinkle, Topamax, Topictal, Toprel)
|
-
41 (26%) experienced major efficacy
-
58 (37%) experienced moderate efficacy
-
24 (15%) experienced slight efficacy
-
14 (9%) experienced no efficacy
-
|
-
36 (23%) experienced severe side effects
-
59 (38%) experienced moderate side effects
-
27 (17%) experienced mild side effects
-
33 (21%) experienced no side effects
|
155 |
Phenytoin
(Phenytoin liquid, Dilantin Infatabs, Epamin, Dilantin Kapseals)
|
-
49 (38%) experienced major efficacy
-
33 (26%) experienced moderate efficacy
-
18 (14%) experienced slight efficacy
-
14 (11%) experienced no efficacy
-
|
-
34 (27%) experienced severe side effects
-
37 (29%) experienced moderate side effects
-
29 (23%) experienced mild side effects
-
28 (22%) experienced no side effects
|
128 |
|
|
-
51 (42%) experienced major efficacy
-
34 (28%) experienced moderate efficacy
-
10 (8%) experienced slight efficacy
-
18 (15%) experienced no efficacy
-
|
-
47 (39%) experienced severe side effects
-
36 (30%) experienced moderate side effects
-
29 (24%) experienced mild side effects
-
9 (7%) experienced no side effects
|
121 |
|
|
-
19 (28%) experienced major efficacy
-
22 (33%) experienced moderate efficacy
-
13 (19%) experienced slight efficacy
-
4 (6%) experienced no efficacy
-
|
-
12 (18%) experienced severe side effects
-
17 (25%) experienced moderate side effects
-
17 (25%) experienced mild side effects
-
21 (31%) experienced no side effects
|
67 |
|
|
-
18 (27%) experienced major efficacy
-
18 (27%) experienced moderate efficacy
-
8 (12%) experienced slight efficacy
-
9 (14%) experienced no efficacy
-
|
-
13 (20%) experienced severe side effects
-
17 (26%) experienced moderate side effects
-
23 (35%) experienced mild side effects
-
13 (20%) experienced no side effects
|
66 |
|
|
-
19 (31%) experienced major efficacy
-
19 (31%) experienced moderate efficacy
-
8 (13%) experienced slight efficacy
-
7 (11%) experienced no efficacy
-
|
-
17 (28%) experienced severe side effects
-
15 (25%) experienced moderate side effects
-
18 (30%) experienced mild side effects
-
11 (18%) experienced no side effects
|
61 |
Clonazepam
(DOM-Clonazepam, Paxam, APO Clonazepam, Clonotril)
|
-
12 (23%) experienced major efficacy
-
17 (32%) experienced moderate efficacy
-
14 (26%) experienced slight efficacy
-
3 (6%) experienced no efficacy
-
|
-
8 (15%) experienced severe side effects
-
9 (17%) experienced moderate side effects
-
20 (38%) experienced mild side effects
-
16 (30%) experienced no side effects
|
53 |
|
|
-
12 (39%) experienced major efficacy
-
9 (29%) experienced moderate efficacy
-
1 (3%) experienced slight efficacy
-
4 (13%) experienced no efficacy
-
|
-
1 (3%) experienced severe side effects
-
6 (19%) experienced moderate side effects
-
19 (61%) experienced mild side effects
-
5 (16%) experienced no side effects
|
31 |
Gabapentin
(Gralise, DOM-Gabapentin, PMS-Gabatentin, APO-Gabapentin)
|
-
4 (14%) experienced major efficacy
-
12 (41%) experienced moderate efficacy
-
3 (10%) experienced slight efficacy
-
4 (14%) experienced no efficacy
-
|
-
10 (34%) experienced severe side effects
-
5 (17%) experienced moderate side effects
-
11 (38%) experienced mild side effects
-
3 (10%) experienced no side effects
|
29 |
|
|
-
12 (44%) experienced major efficacy
-
5 (19%) experienced moderate efficacy
-
3 (11%) experienced slight efficacy
-
4 (15%) experienced no efficacy
-
|
-
6 (22%) experienced severe side effects
-
10 (37%) experienced moderate side effects
-
6 (22%) experienced mild side effects
-
5 (19%) experienced no side effects
|
27 |
|
|
-
5 (21%) experienced major efficacy
-
12 (50%) experienced moderate efficacy
-
3 (13%) experienced slight efficacy
-
3 (13%) experienced no efficacy
-
|
-
6 (25%) experienced severe side effects
-
10 (42%) experienced moderate side effects
-
4 (17%) experienced mild side effects
-
4 (17%) experienced no side effects
|
24 |
Lorazepam
(Sandoz Lorazepam, Lorenin, Temesta, Orfidal)
|
-
20 (83%) experienced major efficacy
-
1 (4%) experienced moderate efficacy
-
2 (8%) experienced slight efficacy
-
0 (0%) experienced no efficacy
-
|
-
3 (13%) experienced severe side effects
-
3 (13%) experienced moderate side effects
-
9 (38%) experienced mild side effects
-
9 (38%) experienced no side effects
|
24 |